Back to Search Start Over

Intralesional Bleomycin for Acquired Immunodeficiency Syndrome-Associated Cutaneous Kaposi's Sarcoma

Intralesional Bleomycin for Acquired Immunodeficiency Syndrome-Associated Cutaneous Kaposi's Sarcoma

Authors :
Georges Lamas
Louis Dominique Lachiver
Sylvie Poignonec
J Soudant
Anne Coutellier
Eric Caumes
Source :
Archives of Dermatology. 131:228
Publication Year :
1995
Publisher :
American Medical Association (AMA), 1995.

Abstract

The treatment of acquired immunodeficiency syndrome (AIDS)—associated Kaposi's sarcoma (KS) is controversial. 1 Local treatments include the argon laser, 2 cryotherapy, 3 and intralesional vinblastine. 3 We report our experience with intralesional bleomycin used in the treatment of cutaneous KS. Methods. Since September 1987, two observers used intralesional bleomycin to treat 15 men with biopsyproven AIDS-associated KS. The median age was 35 years (range, 29 through 63 years). The known risk factor was homosexuality in nine cases and not known in six cases. At inclusion, the median CD4 cell count in 13 patients was 199×10 9 /L (range, 1 to 634×10 9 /L) Cutaneous lesions (not previously treated) were located on both the face and the body. The size of the lesions ranged from 2 to 15 mm. Both macular and nodular lesions were observed. The median number of lesions treated per patient was eight (range, one through 19). Two

Details

ISSN :
0003987X
Volume :
131
Database :
OpenAIRE
Journal :
Archives of Dermatology
Accession number :
edsair.doi...........2931cc1326e417963bf2138243cfaca7
Full Text :
https://doi.org/10.1001/archderm.1995.01690140114026